Searched for
AFFORDABLE INSULIN
Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for Biocon- The hidden cost of looking better: What health insurance covers, and what it leaves you to pay
- 'Thank God' Kiran Mazumdar Shaw did not become a doctor: When Dr Devi Shetty shared a life lesson from Biocon founder's inspiring journey
- Health Ministry releases guidance document on Childhood Diabetes at National SummitThe Guidance Document establishes, for the first time, a structured and standardised national framework for the screening, diagnosis, treat...03 May, 2026, 03.18 PM IST
- This surprising diet helps Type 1 Diabetes patients slash their insulin useA new study suggests a low-fat vegan diet can significantly reduce insulin needs for type 1 diabetes patients. This dietary change may also...23 Oct, 2025, 01.12 AM IST
- Game changer: California launches $11 state brand to slash Diabetes costsCalifornia is set to launch its own low cost insulin under the CalRx beginning from January 1, 2026, representing a major step in the state...17 Oct, 2025, 11.29 PM IST
- Biocon Biologics expands collaboration with Civica to supply affordable insulin in USBiocon Biologics is expanding its partnership with Civica. This new agreement will bring affordable Insulin Glargine to patients in the Uni...17 Oct, 2025, 08.27 PM IST
- Domestic drug companies in a sweet spot as global players look beyond insulinIndian drug cos are increasing their presence in the insulin market. They are competing with multinational corporations. Affordable insulin...20 May, 2025, 12.36 PM IST
- Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the USBiocon Biologics has partnered with Civica to improve access to and affordability of insulin aspart in the U.S. Biocon will supply the insu...07 Mar, 2025, 09.55 AM IST
- Biocon Biologics' arm gets USD 90 mn contract from Malaysian government for supply of insulinsBiocon Biologics, a part of Biocon Ltd, has created a Centre of Excellence (CoE) for insulins in Malaysia with end-to-end capabilities to m...26 Apr, 2022, 10.37 AM IST
- Biocon Biologics interchangeable insulin Semglee gets US FDA approvalBiocon partnered with global healthcare company Viatris Inc to develop Semglee, the first interchangeable biosimilar product approved in th...30 Jul, 2021, 06.49 PM IST
- Biocon Biologics to partner with International Diabetes FederationGlobal Head of Market Access & Policy, Biocon Biologics, Alexander Zach, said:"Given our extensive experience in providing affordable insul...16 Feb, 2021, 11.23 AM IST
- Biocon Biologics signs pact with CSSC in Africa to make insulins available for 10 centsIn Tanzania, there were 897,000 reported cases of diabetes in 2017 and the prevalence of diabetes is 3.6% of the total adult population of ...15 Dec, 2020, 07.36 PM IST
- Biocon gets US FDA nod to launch insulin glargineThe product branded as Semglee has an identical amino acid sequence to Sanofi’s Lantus® and is approved for the same indications. This is t...12 Jun, 2020, 09.54 AM IST
- Kiran Mazumdar-Shaw named EY World Entrepreneur Of The Year 2020, Biocon boss says she won it for her colleaguesShe became the third Indian and second woman to win the Award.05 Jun, 2020, 10.34 AM IST
- Biocon's partner Mylan gets favourable ruling from US patent authority for 4 devices"We are extremely pleased with the US PTAB's ruling in favour of our partner Mylan for four device patents of Sanofi's Lantus SoloSTAR. Thi...01 Jun, 2020, 03.41 PM IST
- Biocon sees a sweet spot with its affordable insulin in USThe biotech firm is also planning to provide its rh-insulin to middle- and low-income countries at less than 10 cents a day. Biocon Biologi...05 Dec, 2019, 08.22 AM IST
- European Medicines Agency accepts marketing application of Biocon, Mylan productMylan and Biocon, which have co-developed insulin glargine, look forward to offering another insulin treatment option for diabetic patients.03 Nov, 2016, 08.48 PM IST
- Biocon targets emerging, developed markets with biosimilars"Biocon aims to provide high quality biosimilars to patients across the world, both in emerging and developed markets," Kiran Mazumdar-Shaw...22 Oct, 2015, 03.47 PM IST
- Biocon opens facility to produce devices for insulin portfolioSpread over 10,000 square feet, the facility will manufacture pen like delivery devices for people with diabetes in India and other parts o...15 Sep, 2015, 11.16 PM IST
Load More
